GSK Q3 profit rises 29% to ₹296 crore, revenue up 10%
after close1 source ↓written by the desknot a recommendation
- in consolidated post-tax
- 28.6% increase
- for Q3 FY26
- ₹296 crore
- a year ago
- ₹230 crore
- from operations rose
- 9.7% YoY
- ₹1,041 crore
Pharma player GlaxoSmithKline Pharmaceuticals reported a 28.6% increase in consolidated post-tax profit to ₹296 crore for Q3 FY26, up from ₹230 crore a year ago. Revenue from operations rose 9.7% YoY to ₹1,041 crore. This strong performance may enhance market sentiment for the pharma sector.
• PAT: ₹296 crore
• Revenue: ₹1,041 crore
• YoY growth: 10%
Traders should monitor GSK's stock for potential upward momentum.
Not investment advice. For informational purposes only.